bufomix easyhaler 80 mikrogramov/4,5 mikrograma na odmerek prašek za inhaliranje
orion corporation - budezonid - prašek za inhaliranje, odmerjeni - budezonid 80 µg / 1 odmerek - formoterol in budezonid
bufomix easyhaler 160 mikrogramov/4,5 mikrograma na odmerek prašek za inhaliranje
orion corporation - budezonid, formoterolfumarat dihidrat - prašek za inhaliranje, odmerjeni - budezonid 160 µg / 1 odmerek; formoterolfumarat dihidrat 4,5 µg / 1 odmerek - formoterol in budezonid
bufomix easyhaler 320 mikrogramov/9 mikrogramov na odmerek prašek za inhaliranje
orion corporation - budezonid, formoterolfumarat dihidrat - prašek za inhaliranje, odmerjeni - budezonid 320 µg / 1 odmerek; formoterolfumarat dihidrat 9 µg / 1 odmerek - formoterol in budezonid
bufar easyhaler 80 mikrogramov/4,5 mikrograma na odmerek prašek za inhaliranje
orion corporation - budezonid - prašek za inhaliranje - budezonid 80 µg / 1 odmerek - formoterol in budezonid
symbicort 160 mikrogramov/4,5 mikrograma na vdih inhalacijska suspenzija pod tlakom
astrazeneca ab - budezonid; formoterolijev fumarat dihidrat - inhalacijska suspenzija pod tlakom - budezonid 160 µg / 1 odmerek formoterolijev fumarat dihidrat4,5 µg / 1 odmerek; formoterolijev fumarat dihidrat 4,5 µg / 1 odmerek - formoterol in budezonid
trimbow
chiesi farmaceutici s.p.a. - beclometasone dipropionate, formoterol fumarate dihidrat, glycopyrronium bromid - pljučna bolezen, kronična obstruktivna bolezen - zdravila za obstruktivne pljučne bolezni, - maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and high dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year. copdmaintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or a combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5. asthmamaintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.
riarify (previously chf 5993 chiesi farmaceutici s.p.a.)
chiesi farmaceutici s.p.a. - formoterol fumarate dihydrate, glycopyrronium, beclometasone dipropionate - pljučna bolezen, kronična obstruktivna bolezen - zdravila za obstruktivne pljučne bolezni, - vzdrževalnega zdravljenja pri odraslih bolnikih z zmerno do hudo kronična obstruktivna pljučna bolezen (kopb), ki ni primerno obravnavana kombinacija inhalacijski kortikosteroidi in dolgotrajnim delovanjem beta2-agonist (učinkov na simptomi nadzor in preprečevanje poslabšanj glej oddelek 5.
trydonis
chiesi farmaceutici s.p.a. - beclometasone dipropionate, formoterol fumarate dihidrat, glycopyrronium - pljučna bolezen, kronična obstruktivna bolezen - zdravila za obstruktivne pljučne bolezni, - vzdrževalnega zdravljenja pri odraslih bolnikih z zmerno do hudo kronična obstruktivna pljučna bolezen (kopb), ki ni primerno obravnavana kombinacija inhalacijski kortikosteroidi in dolgotrajnim delovanjem beta2-agonist (učinkov na simptomi nadzor in preprečevanje poslabšanj glej oddelek 5.
trixeo aerosphere
astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - pljučna bolezen, kronična obstruktivna bolezen - zdravila za obstruktivne pljučne bolezni, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.
riltrava aerosphere
astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - pljučna bolezen, kronična obstruktivna bolezen - zdravila za obstruktivne pljučne bolezni, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.